Methods and compositions useful in preventing equine influenza
US4631191A · kind A · utility
29Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 1985 |
| Grant date | Dec 23, 1986 |
| Priority date | — |
| Expiry date | Jun 20, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/811
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Recombinant vaccines for immunizing horses against equine influenza virus (EIV) are disclosed. The DNA sequences encoding the hemagluttinin (HA) and neuraminidase (NA) glycoproteins from the two strains of EIV currently infective in horses are used to construct vaccinia carried vaccines, to design synthetic peptides for primer and booster administration, and to permit recombinant synthesis of HA and/or NA protein based vaccines. These DNA sequences also provide probes useful for preparing similar vaccines from fresh isolates of new strains generated by genetic drift.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.